Clarification

Hachinski, Vladimir

doi:10.1161/01.str.0000242116.89927.20

Cited by 3 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Stroke can therefore initiate rapid cognitive decline. This forms a basis for the etiology of vascular dementia and the more recent, broader concept of vascular cognitive impairment, which encompasses mild cognitive impairment resulting from vascular disease processes through to dementia following stroke (Hachinski et al, 2006). …”

Section: Clinical Stroke and Dementiamentioning

confidence: 99%

Stroke Prevention and Cognitive Reserve: Emerging Approaches to Modifying Risk and Delaying Onset of Dementia

Willis¹,

Hakim²

2013

Front. Neurol.

View full text Add to dashboard Cite

Demographic changes and improvements in health care are projected to result in dramatic increases in the prevalence of dementia. Alzheimer’s disease is widely considered to be the primary cause of dementia – a disease for which there is currently no cure nor effective treatment, and for which it is thought that little can be done to mitigate risk. However, an increasing understanding of the role and extent of vascular contributions to the development of dementia, and appreciation of the interactions between stroke and Alzheimer’s disease, suggest that targeting vascular risk factors may be very beneficial in reducing the impact of dementia. We also describe how active stimulation of the brain throughout the life course builds cognitive reserve that can offset or compensate for cognitive decline in later life. Finally, we discuss the implications of these emerging approaches for dementia prevention and advocate for the urgent implementation of more extensive public health strategies to improve vascular health.

show abstract

Section: Clinical Stroke and Dementiamentioning

confidence: 99%

Stroke Prevention and Cognitive Reserve: Emerging Approaches to Modifying Risk and Delaying Onset of Dementia

Willis¹,

Hakim²

2013

Front. Neurol.

View full text Add to dashboard Cite

show abstract

“…2,3 In fact, on the page preceding the article submitted by Hess in April 2006, the Editor-in-Chief of Stroke, Dr Hachinski, clearly states that Dr Lees' appointment as section coeditor for Emerging Therapies began on July 1, 2006 and that "Dr Lees had nothing to do with the choice or editing of these articles." 4 No impropriety occurred. Another mis-statement by Dr Ginsberg is "Given the marginal findings and questionable methods of SAINT I, it is natural to question the wisdom of the rationale for proceeding to invest the tens of millions of dollars and thousands of medical-personnel hours needed to conduct SAINT II."…”

Section: To the Editormentioning

confidence: 99%